- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 8 residues within 4Å:- Chain A: L.183, S.184, H.186
- Chain C: R.171, H.186
- Ligands: SO4.27, EDO.66, GOL.77
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain C- Water bridges: A:S.184, A:A.207, C:R.269, C:V.270
- Salt bridges: A:H.186, C:R.171, C:H.186
SO4.23: 4 residues within 4Å:- Chain A: L.214, H.215, P.216
- Chain B: Q.7
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:Q.7
- Salt bridges: A:H.215
SO4.27: 7 residues within 4Å:- Chain A: R.171, H.186
- Chain C: S.184, H.186
- Ligands: SO4.2, EDO.11, EDO.21
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain A- Water bridges: C:S.184, C:A.207, A:R.171, A:R.269
- Salt bridges: C:H.186, A:R.171, A:H.186
SO4.30: 2 residues within 4Å:- Chain B: S.105, R.106
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.106
- Salt bridges: B:R.106
SO4.31: 2 residues within 4Å:- Chain B: N.108, R.112
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.108, B:N.108
- Salt bridges: B:R.112
SO4.36: 8 residues within 4Å:- Chain B: R.171, H.186
- Chain D: L.183, S.184, H.186
- Ligands: GOL.54, EDO.56, SO4.82
7 PLIP interactions:3 interactions with chain D, 4 interactions with chain B- Hydrogen bonds: D:L.183
- Water bridges: D:A.207, B:R.171, B:H.186
- Salt bridges: D:H.186, B:R.171, B:H.186
SO4.47: 3 residues within 4Å:- Chain B: K.118, Q.331, H.333
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.331
- Salt bridges: B:K.118, B:H.333
SO4.60: 1 residues within 4Å:- Chain C: K.328
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:K.328
SO4.82: 7 residues within 4Å:- Chain B: L.183, S.184, H.186
- Chain D: R.171, H.186
- Ligands: SO4.36, EDO.95
7 PLIP interactions:5 interactions with chain D, 2 interactions with chain B- Water bridges: D:R.171, D:H.186, D:V.270, B:A.207
- Salt bridges: D:R.171, D:H.186, B:H.186
SO4.104: 3 residues within 4Å:- Chain D: S.105, R.106
- Ligands: YOJ.102
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:R.106
- Salt bridges: D:R.106
- 75 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 2 residues within 4Å:- Chain A: Y.239
- Ligands: YOJ.20
Ligand excluded by PLIPEDO.4: 6 residues within 4Å:- Chain A: Q.66, P.75, K.76, I.77
- Chain B: Y.172, E.176
Ligand excluded by PLIPEDO.5: 4 residues within 4Å:- Chain A: W.148, K.149, G.152, F.153
Ligand excluded by PLIPEDO.6: 3 residues within 4Å:- Chain A: R.177, E.229, V.230
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: L.40, M.41, D.43, F.71, L.72, R.73
Ligand excluded by PLIPEDO.8: 3 residues within 4Å:- Chain A: E.55, K.59
- Ligands: EDO.22
Ligand excluded by PLIPEDO.11: 10 residues within 4Å:- Chain A: N.164, S.167, R.171, W.188, V.270, H.271, P.272
- Chain B: L.70
- Ligands: EDO.21, SO4.27
Ligand excluded by PLIPEDO.12: 8 residues within 4Å:- Chain A: S.202, G.203, N.205, G.208, S.210
- Chain C: S.202, G.203, G.208
Ligand excluded by PLIPEDO.13: 1 residues within 4Å:- Chain A: T.3
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: A.98, N.113, N.138
- Ligands: NAI.1, YOJ.20
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain A: W.148, P.154, K.155
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain A: K.149, G.152
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: N.88, S.128, P.129, N.130, C.131
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain A: Q.20, N.21, K.90, I.263, M.264, Q.297
- Chain D: Q.20
Ligand excluded by PLIPEDO.21: 8 residues within 4Å:- Chain A: L.183, D.258, R.269, H.271
- Chain B: L.70, F.71
- Ligands: EDO.11, SO4.27
Ligand excluded by PLIPEDO.22: 5 residues within 4Å:- Chain A: E.55, G.80, K.81, D.82
- Ligands: EDO.8
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain A: K.243, K.245
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain A: Y.172, G.175, E.176, V.180, P.182
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain A: A.30, Y.247
- Chain B: Y.247
- Ligands: EDO.45
Ligand excluded by PLIPEDO.29: 2 residues within 4Å:- Chain B: E.329
- Ligands: YOJ.50
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain B: L.40, M.41, D.43, F.71, L.72, R.73
Ligand excluded by PLIPEDO.34: 4 residues within 4Å:- Chain B: V.53, I.54, E.55, D.56
Ligand excluded by PLIPEDO.35: 6 residues within 4Å:- Chain B: Q.20, N.21, K.90, M.264
- Chain C: Q.20, N.21
Ligand excluded by PLIPEDO.37: 3 residues within 4Å:- Chain B: M.62, V.78, S.79
Ligand excluded by PLIPEDO.38: 6 residues within 4Å:- Chain B: Y.145, W.324, Q.327, L.330, F.332, H.334
Ligand excluded by PLIPEDO.39: 3 residues within 4Å:- Chain B: E.236, E.240, K.243
Ligand excluded by PLIPEDO.41: 1 residues within 4Å:- Chain B: R.268
Ligand excluded by PLIPEDO.42: 3 residues within 4Å:- Chain B: L.280, Y.281, K.305
Ligand excluded by PLIPEDO.43: 4 residues within 4Å:- Chain B: T.220, D.221, K.222, K.228
Ligand excluded by PLIPEDO.44: 4 residues within 4Å:- Chain B: P.154, N.156, R.157
- Chain C: E.15
Ligand excluded by PLIPEDO.45: 8 residues within 4Å:- Chain A: W.250
- Chain B: A.30, M.33, A.34, Y.247, S.249, W.250
- Ligands: EDO.26
Ligand excluded by PLIPEDO.46: 2 residues within 4Å:- Chain B: H.333, H.334
Ligand excluded by PLIPEDO.48: 3 residues within 4Å:- Chain B: E.55, D.56, K.59
Ligand excluded by PLIPEDO.49: 2 residues within 4Å:- Chain B: W.324, K.328
Ligand excluded by PLIPEDO.52: 3 residues within 4Å:- Chain B: V.53
- Ligands: NAI.32, EDO.53
Ligand excluded by PLIPEDO.53: 5 residues within 4Å:- Chain B: A.98, R.99, Q.101, R.112
- Ligands: EDO.52
Ligand excluded by PLIPEDO.55: 3 residues within 4Å:- Chain B: L.173, E.176, R.177
Ligand excluded by PLIPEDO.56: 7 residues within 4Å:- Chain A: L.70
- Chain B: L.183, D.258, R.269, H.271
- Ligands: SO4.36, GOL.54
Ligand excluded by PLIPEDO.58: 4 residues within 4Å:- Chain B: P.19, Q.20, K.90
- Chain C: Q.20
Ligand excluded by PLIPEDO.59: 3 residues within 4Å:- Chain B: D.6, Y.10
- Chain C: K.305
Ligand excluded by PLIPEDO.61: 3 residues within 4Å:- Chain C: P.154, N.156, R.157
Ligand excluded by PLIPEDO.63: 6 residues within 4Å:- Chain C: Q.66, P.75, K.76, I.77
- Chain D: Y.172, E.176
Ligand excluded by PLIPEDO.64: 4 residues within 4Å:- Chain C: R.177, E.229, V.230, Q.233
Ligand excluded by PLIPEDO.65: 6 residues within 4Å:- Chain C: L.40, M.41, D.43, F.71, L.72, R.73
Ligand excluded by PLIPEDO.66: 9 residues within 4Å:- Chain C: N.164, S.167, R.171, W.188, V.270, P.272
- Chain D: L.70
- Ligands: SO4.2, GOL.77
Ligand excluded by PLIPEDO.67: 3 residues within 4Å:- Chain C: A.98, R.99
- Ligands: NAI.62
Ligand excluded by PLIPEDO.68: 3 residues within 4Å:- Chain C: W.148, P.154, K.155
Ligand excluded by PLIPEDO.69: 2 residues within 4Å:- Chain C: D.223, K.224
Ligand excluded by PLIPEDO.70: 4 residues within 4Å:- Chain C: E.192, S.196, S.319, T.322
Ligand excluded by PLIPEDO.71: 5 residues within 4Å:- Chain C: P.199, W.201, K.228, H.231, R.315
Ligand excluded by PLIPEDO.72: 4 residues within 4Å:- Chain C: T.220, D.221, K.222, K.228
Ligand excluded by PLIPEDO.73: 2 residues within 4Å:- Chain C: T.309, S.310
Ligand excluded by PLIPEDO.74: 2 residues within 4Å:- Chain C: E.240
- Chain D: K.59
Ligand excluded by PLIPEDO.75: 3 residues within 4Å:- Chain C: Y.239
- Ligands: GOL.78, EDO.80
Ligand excluded by PLIPEDO.76: 2 residues within 4Å:- Chain C: W.324, K.328
Ligand excluded by PLIPEDO.80: 3 residues within 4Å:- Chain C: K.243
- Ligands: EDO.75, GOL.78
Ligand excluded by PLIPEDO.83: 6 residues within 4Å:- Chain A: L.267, R.268
- Chain C: G.179, V.180, H.181
- Chain D: P.75
Ligand excluded by PLIPEDO.84: 5 residues within 4Å:- Chain B: S.202, G.208
- Chain D: S.202, G.208, S.210
Ligand excluded by PLIPEDO.85: 4 residues within 4Å:- Chain D: R.177, E.229, V.230, Q.233
Ligand excluded by PLIPEDO.86: 6 residues within 4Å:- Chain D: E.55, L.58, K.59, M.62, S.79, G.80
Ligand excluded by PLIPEDO.87: 3 residues within 4Å:- Chain D: G.80, K.81, D.82
Ligand excluded by PLIPEDO.88: 3 residues within 4Å:- Chain D: A.98, R.99, R.112
Ligand excluded by PLIPEDO.89: 2 residues within 4Å:- Chain D: K.57, R.99
Ligand excluded by PLIPEDO.91: 5 residues within 4Å:- Chain D: L.40, M.41, D.43, F.71, R.73
Ligand excluded by PLIPEDO.93: 5 residues within 4Å:- Chain A: P.75
- Chain B: H.181
- Chain D: N.266, L.267, R.268
Ligand excluded by PLIPEDO.94: 7 residues within 4Å:- Chain D: N.266, R.268, G.296, Q.297, N.298, G.299, S.301
Ligand excluded by PLIPEDO.95: 8 residues within 4Å:- Chain C: L.70
- Chain D: S.167, R.171, W.188, V.270, P.272
- Ligands: SO4.82, EDO.105
Ligand excluded by PLIPEDO.96: 2 residues within 4Å:- Chain D: Y.10, N.11
Ligand excluded by PLIPEDO.97: 3 residues within 4Å:- Chain D: W.148, P.154, K.155
Ligand excluded by PLIPEDO.98: 2 residues within 4Å:- Chain D: T.309, S.310
Ligand excluded by PLIPEDO.99: 3 residues within 4Å:- Chain D: E.236, E.240, K.243
Ligand excluded by PLIPEDO.100: 3 residues within 4Å:- Chain D: P.122, N.123, K.126
Ligand excluded by PLIPEDO.101: 2 residues within 4Å:- Chain D: W.324, K.328
Ligand excluded by PLIPEDO.103: 2 residues within 4Å:- Chain D: Y.239
- Ligands: YOJ.102
Ligand excluded by PLIPEDO.105: 5 residues within 4Å:- Chain D: L.183, D.258, R.269, H.271
- Ligands: EDO.95
Ligand excluded by PLIP- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.9: 2 residues within 4Å:- Chain A: K.126, Y.127
No protein-ligand interaction detected (PLIP)GOL.54: 10 residues within 4Å:- Chain A: L.70
- Chain B: N.164, S.167, R.171, W.188, V.270, H.271, P.272
- Ligands: SO4.36, EDO.56
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.164, B:R.171, B:V.270
- Water bridges: B:R.171, B:G.187
GOL.77: 7 residues within 4Å:- Chain C: L.183, D.258, R.269, H.271
- Chain D: L.70
- Ligands: SO4.2, EDO.66
5 PLIP interactions:1 interactions with chain A, 2 interactions with chain C, 1 interactions with chain D, 1 interactions with chain B- Water bridges: A:L.183, D:R.73, B:R.73
- Hydrogen bonds: C:R.269, C:H.271
GOL.78: 6 residues within 4Å:- Chain C: E.236, Y.239, E.240, K.243
- Ligands: EDO.75, EDO.80
No protein-ligand interaction detected (PLIP)GOL.81: 3 residues within 4Å:- Chain C: Y.239, I.242
- Ligands: YOJ.79
No protein-ligand interaction detected (PLIP)GOL.90: 4 residues within 4Å:- Chain D: Q.101, E.104, N.108, R.112
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Q.101, D:N.108
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.10: 3 residues within 4Å:- Chain A: K.149, Q.331, F.332
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.149, A:K.149, A:F.332
PEG.17: 8 residues within 4Å:- Chain A: V.198, P.199, W.201, K.228, H.231, E.311, E.312, R.315
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.228, A:E.312, A:R.315
PEG.28: 4 residues within 4Å:- Chain A: M.41, D.43
- Chain D: M.41, D.43
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: D:M.41, A:M.41
PEG.40: 5 residues within 4Å:- Chain B: Q.100, R.106, Y.239, I.242
- Ligands: YOJ.50
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.100, B:R.106, B:Y.239
PEG.51: 2 residues within 4Å:- Chain B: T.309, S.310
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.310
PEG.57: 4 residues within 4Å:- Chain B: Q.20
- Chain C: K.90, K.132, Q.297
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:K.132, C:I.263
- 4 x YOJ: 5-[(5'-{1-(4-carboxy-1,3-thiazol-2-yl)-5-(cyclopropylmethyl)-4-[(3-fluoro-4-sulfamoylphenyl)methyl]-1H-pyrazol-3-yl}-2'-fluoro[1,1'-biphenyl]-4-yl)oxy]-1H-1,2,3-triazole-4-carboxylic acid(Non-covalent)
YOJ.20: 23 residues within 4Å:- Chain A: R.106, L.109, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323, I.326
- Ligands: NAI.1, EDO.3, EDO.14
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:L.109, A:V.110, A:N.138, A:A.238, A:Y.239
- Hydrogen bonds: A:R.106, A:N.138, A:D.141, A:I.142, A:E.192, A:E.192, A:T.248
- Water bridges: A:R.106, A:R.106
- Salt bridges: A:R.169, A:H.193
- Halogen bonds: A:R.106
YOJ.50: 24 residues within 4Å:- Chain B: R.106, L.107, L.109, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323, I.326
- Ligands: EDO.29, NAI.32, PEG.40
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:R.106, B:L.109, B:V.110, B:N.138, B:A.238, B:Y.239
- Hydrogen bonds: B:N.138, B:D.141, B:D.141, B:I.142, B:E.192
- Salt bridges: B:R.169, B:H.193
YOJ.79: 23 residues within 4Å:- Chain C: R.106, L.107, L.109, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323, I.326
- Ligands: NAI.62, GOL.81
15 PLIP interactions:15 interactions with chain C- Hydrophobic interactions: C:L.109, C:V.110, C:N.138, C:P.139, C:A.238, C:Y.239
- Hydrogen bonds: C:N.138, C:D.141, C:D.141, C:I.142, C:E.192, C:E.192, C:T.248
- Salt bridges: C:R.169, C:H.193
YOJ.102: 24 residues within 4Å:- Chain D: R.106, L.107, L.109, V.110, N.138, P.139, V.140, D.141, I.142, L.165, R.169, E.192, H.193, G.194, D.195, A.238, Y.239, I.242, T.248, L.323, I.326
- Ligands: NAI.92, EDO.103, SO4.104
15 PLIP interactions:15 interactions with chain D- Hydrophobic interactions: D:L.109, D:V.110, D:N.138, D:P.139, D:A.238, D:Y.239
- Hydrogen bonds: D:L.107, D:N.138, D:D.141, D:I.142, D:E.192
- Salt bridges: D:R.106, D:R.169, D:H.193
- Halogen bonds: D:R.106
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ding, J. et al., Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria. ACS Medicinal Chemistry Letters (2021)
- Release Date
- 2021-07-14
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
- 75 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 4 x YOJ: 5-[(5'-{1-(4-carboxy-1,3-thiazol-2-yl)-5-(cyclopropylmethyl)-4-[(3-fluoro-4-sulfamoylphenyl)methyl]-1H-pyrazol-3-yl}-2'-fluoro[1,1'-biphenyl]-4-yl)oxy]-1H-1,2,3-triazole-4-carboxylic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ding, J. et al., Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria. ACS Medicinal Chemistry Letters (2021)
- Release Date
- 2021-07-14
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D